161 related articles for article (PubMed ID: 141763)
41. Progress in the pharmacotherapy of Parkinsonism.
Calne DB; Eisler T; Gopinathan G; Williams A
Adv Biochem Psychopharmacol; 1980; 23():237-43. PubMed ID: 6104907
[No Abstract] [Full Text] [Related]
42. [Treatment of Parkinson's disease with bromocriptine].
Castaigne P; Laplane D; Bousser MG; Bories F
Nouv Presse Med; 1976 Apr; 6(17):1482. PubMed ID: 1037400
[No Abstract] [Full Text] [Related]
43. Idiopathic dystonia-parkinsonism with marked diurnal fluctuation of symptoms.
Sunohara N; Mano Y; Ando K; Satoyoshi E
Ann Neurol; 1985 Jan; 17(1):39-45. PubMed ID: 3985584
[TBL] [Abstract][Full Text] [Related]
44. [Attempted direct etiological treatment of Huntington's chorea. Case reports].
Majeron MA; Ambrosoli C; Armocida G; Finavera L; Quisi Q
Minerva Med; 1980 Apr; 71(16):1213-20. PubMed ID: 6445524
[TBL] [Abstract][Full Text] [Related]
45. [Treatment of parkinsonism with dopaminergic system agonists].
Dowzenko A
Neurol Neurochir Pol; 1976; 10(4):579-82. PubMed ID: 958587
[No Abstract] [Full Text] [Related]
46. Endocrine aspects of bromocriptine therapy in Parkinsonism.
Shaw KM; Lees AJ; Franks S; Daggett P; Thompson BD; Stern GM
J Neural Transm; 1978; 43(2):153-60. PubMed ID: 104006
[TBL] [Abstract][Full Text] [Related]
47. Letter: Bromocriptine in parkinsonism.
Lees AJ; Shaw KM; Stern GM
Lancet; 1975 Oct; 2(7937):709-10. PubMed ID: 52084
[No Abstract] [Full Text] [Related]
48. Bromocriptine and dopaminergic function in Huntington disease.
Loeb C; Roccatagliata G; Albano C; Besio G
Neurology; 1979 May; 29(5):730-4. PubMed ID: 155784
[TBL] [Abstract][Full Text] [Related]
49. Treatment of parkinsonism with bromocriptine.
Calne DB; Teychenne PF; Leigh PN; Bamji AN; Greenacre JK
Lancet; 1974 Dec; 2(7893):1355-6. PubMed ID: 4143315
[No Abstract] [Full Text] [Related]
50. Monoamine metabolism and depression in Parkinson patients.
Puite JK; Schut T; van Praag HM; Lakke JP
Psychiatr Neurol Neurochir; 1973; 76(1):61-70. PubMed ID: 4699106
[No Abstract] [Full Text] [Related]
51. Dopaminergic mechanisms in patients with extrapyramidal disease.
Chase TN; Shoulson I
Adv Neurol; 1975; 9():359-66. PubMed ID: 1146660
[No Abstract] [Full Text] [Related]
52. [Results of CB 154 in the treatment of acromegaly in France (author's transl)(proceedings)].
Bricaire H
Ann Endocrinol (Paris); 1976; 37(4):305-8. PubMed ID: 1037363
[No Abstract] [Full Text] [Related]
53. Beta-adrenergic receptor subtypes in the basal ganglia of patients with Huntington's chorea and Parkinson's disease.
Waeber C; Rigo M; Chinaglia G; Probst A; Palacios JM
Synapse; 1991 Aug; 8(4):270-80. PubMed ID: 1656540
[TBL] [Abstract][Full Text] [Related]
54. Psychiatric effects of bromocriptine and lergotrile in Parkinsonian patients.
Serby M; Angrist B; Lieberman A
Adv Biochem Psychopharmacol; 1980; 23():287-92. PubMed ID: 6104908
[No Abstract] [Full Text] [Related]
55. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
56. An ergot derivative in the treatment of Parkinson's disease.
Calne DB; Shoulson I; Kartzinel R
Postgrad Med J; 1976; 52suppl 1():81-5. PubMed ID: 183198
[No Abstract] [Full Text] [Related]
57. [Treatment of acromegaly by dibromoergocryptine and cyproheptadine (author's transl)(proceedings)].
Mornex R; Berthezene F; Claustrat B; Fischer C
Ann Endocrinol (Paris); 1976; 37(4):303-4. PubMed ID: 1037362
[No Abstract] [Full Text] [Related]
58. Bromocriptine and Huntington's chorea.
Frattola L; Albizzatir MG; Trabucchi M
Arch Neurol; 1978 Jan; 35(1):60. PubMed ID: 145841
[No Abstract] [Full Text] [Related]
59. Ergot derivatives for Parkinsonism.
Calne DB; Williams AC; Nutt JG; Neophytides A; Eisler T; Teychenne PF
Med J Aust; 1978 Nov; 2(3 Suppl):25-6. PubMed ID: 34083
[TBL] [Abstract][Full Text] [Related]
60. Changes in pituitary hormones serum levels in bromocryptine-treated parkinsonian patients.
Polleri A; Carolei A; Rolandi E; Masturzo P; Meco G; Agnoli A
Neuropsychobiology; 1977; 3(1):42-8. PubMed ID: 578293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
